Clinical Trials Directory

Trials / Unknown

UnknownNCT05407467

KurCoSmart Effects on People With Type 2 DM

KurCoSmart Effects on People With Type 2 DM: a Randomized, Open Trial

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Universitas Sebelas Maret · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to evaluate the effect of curcumin and virgin coconut oil extract supplementation on people with type 2 DM, including blood glucose, HbA1c levels, inflammation, body weight and insulin resistance evaluation

Detailed description

The investigators give Kurcosmart supplementation aside from diabetes standard treatment to evaluate its benefits on people with type 2 DM, considering its effect on controlling fasting and prandial blood glucose, reducing HbA1c level, controlling inflammation degree; and repairing insulin resistance

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCurcumin and virgin coconut oil extract (KurCo Smart)we give 2 tablets of curcumin and virgin coconut oil extract thrice a day for 30 days and evaluate the result

Timeline

Start date
2022-06-01
Primary completion
2022-08-01
Completion
2022-09-01
First posted
2022-06-07
Last updated
2022-06-07

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT05407467. Inclusion in this directory is not an endorsement.